S'abonner

Patient characteristics, presentation, causal microorganisms, and overall mortality in the NatIonal Danish endocarditis stUdieS (NIDUS) registry - 07/04/25

Doi : 10.1016/j.ahj.2025.02.006 
Katra Hadji-Turdeghal, MD a, #, Peter Laursen Graversen, MD a, #, Jacob Eifer Møller, MDDMSc a, b, c, Niels Eske Bruun, MDDMSc d, e, l, Jonas A. Povlsen, MDPh.D. g, Claus Moser, MDPh.D h, i, Morten Smerup, MDPh.D. j, Peter Søgaard, MDDMSc k, l, Hanne Sortsøe Jensen, MDPh.D k, Peter Godsk Jørgensen, MD m, Andreas Dalsgaard Jensen, MD a, Jeppe K. Petersen, MDPhD a, Eva Havers-Borgersen, MD a, Jannik Helweg-Larsen, MDPh.D. n, Daniel Faurholt-Jepsen, MDPh.D. n, e, Henning Bundgaard, MDDMSc a, e, Kasper Iversen, MDDMSc e, f, Lauge Østergaard, MDPhD. a, o, Lars Køber, MDDMSc a, e, Emil L. Fosbøl, MDPhD. a, e,
a Department of Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark 
b Research Unit of Cardiology, Department of Cardiology, Odense University Hospital, Odense, Denmark 
c Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark 
d Department of Cardiology, Zealand University Hospital, Roskilde, Denmark 
e Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark 
f Department of Emergency Medicine, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark 
g Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark 
h Department of Clinical Microbiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark 
i Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark 
j Department of Cardiothoracic Surgery, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark 
k Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark 
l Department of Clinical Medicine, Aalborg University, Aalborg, Denmark 
m Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark 
n Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark 
o Department of Cardiology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark 

Reprint requests: Emil L. Fosbøl, MD, PhD, Department of Cardiology, Copenhagen University Hospital -Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, DenmarkDepartment of CardiologyCopenhagen University Hospital -RigshospitaletBlegdamsvej 9Copenhagen2100Denmark

Highlights

What is already known:
Much of the previous studies on infective endocarditis(IE) is often based on cohorts from tertiary hospitals or retrospective registry studies, which may not represent the whole IE population, creating a need for nationwide characterization.
What this study adds:
The NIDUS registry is a validated national cohort encompassing all IE cases in Denmark from 2016 to 2021, including 3,557 patients (79.6% classified as definite IE and 20.4% as possible IE).
It provides comprehensive insights into IE demographics, clinical features, comorbidities, and outcomes from a contemporary nationwide cohort: most patients presented with fever (61.1%), followed by dyspnea (33.0%) and myalgias (27.0%). Sepsis was identified in 828 (23.3%) patients, and 378 (10.6%) exhibited signs of embolization at admission.
In the NIDUS registry, in-hospital mortality was 17.3%, 1-year mortality reached 31.3%, 19.4% of the patients underwent surgical treatment during hospitalization, and Staphylococcus aureus was the most common pathogen.

Le texte complet de cet article est disponible en PDF.

ABSTRACT

Background

Most knowledge on infective endocarditis (IE) comes from large IE cohorts that include patients from tertiary hospitals, leading to referral bias and retrospective population-based studies. This highlights the need for a more detailed characterization of IE in unselected patient cohorts.

Methods

In the National Danish Endocarditis Studies (NIDUS) registry, all hospitalizations in Denmark from 2016 to 2021 with an IE diagnosis were reviewed and validated using electronic medical records (EMR) by healthcare professionals under the supervision of IE experts. Episodes meeting the European Society of Cardiology 2015 modified diagnostic criteria for possible or definite IE were included.

Results

We screened 4390 unique patients, of whom 3557 (81%) were included in the NIDUS registry. Of the 3557 unique patients, 2832 (79.6%) were classified as definite IE and 725 (20.4%) as possible IE. The age was 73.7 years, and most patients were men (68.3%). In total, 689 (19.4%) underwent surgery during hospitalization. The most frequent comorbidities were diabetes (23.7%), heart failure (18.7%), and chronic kidney disease (17.4%). Most patients presented with fever (61.1%), followed by dyspnea (33.0%) and myalgias (27.0%). Sepsis was found in 828 (23.3%) patients, while 378 (10.6%) had signs of embolization at admission. Positive blood cultures were identified in 3191 (89.7%) patients, and the most frequent microbiological etiology was Staphylococcus aureus (31.9%). The in-hospital mortality was 17.3%, and the 1-year mortality rate was 31.3%.

Conclusion

The NatIonal Danish endocarditis studies (NIDUS) registry provides comprehensive, granular, and nationwide data on a cohort of patients with infective endocarditis, revealing that when selection is not restricted to tertiary hospitals or voluntary registries, some important differences emerge. Patients with IE are on average older, have a similar burden of comorbidities, and less often undergo surgery. Minimizing selection bias with the use of a national registry provides a clearer picture of IE as it occurs in real-world clinical settings.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Image, graphical abstract

Le texte complet de cet article est disponible en PDF.

Plan


© 2025  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 285

P. 119-132 - juillet 2025 Retour au numéro
Article précédent Article précédent
  • Targeted therapy with a localized abluminal groove low-dose sirolimus-eluting bioabsorbable polymer coronary stent in chronic total occlusions: The TARGET CTO non-inferiority randomized trial
  • Geng Wang, Ruiyan Zhang, Shao-Liang Chen, Jian'an Wang, Yi Li, Ming Zheng, Ruifen Cao, Yitong Ma, Zhiqi Sun, Xueqi Li, Xi Su, Wen Lu, Yawei Xu, Xue Li, Yang Li, Fucheng Sun, Yaling Han, TARGET CTO Investigators
| Article suivant Article suivant
  • Cardiovascular health, lifestyle factors, and social determinants among Hispanic or Latino adults in the United States
  • Frans Serpa, Sudheesha Perera, Daniel E. Cruz, Jose F. Figueroa, Fatima Rodriguez, Daniel B. Kramer, Rishi K. Wadhera

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.